Istanbul, Turkey

Yusuf Serhat Is

This inventor holds 2 USPTO granted patents. Top assignees: Agri Ibrahim Cecen Universitesi Strateji Daire Bask., Bahçesehir Üniversitesi, Istanbul Gedik Universitesi. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuf Serhat Is. Retrieved from https://idiyas.com/inventor/yusuf-serhat-is

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yusuf Serhat Is: Innovator in Neurodegenerative Disease Treatment

Introduction

Yusuf Serhat Is is a notable inventor based in Besiktas, Istanbul, Turkey. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and development.

Latest Patents

Yusuf Serhat Is holds a patent for a selective MAO-B inhibitor known as DRG-MAOB-2. This invention relates to a compound represented by formula (I) or a pharmaceutically acceptable derivative thereof, which serves as a novel inhibitor of MAO-B. This breakthrough has the potential to impact the treatment of various neurodegenerative diseases.

Career Highlights

Throughout his career, Yusuf Serhat Is has worked with esteemed institutions such as Bahçesehir University and Agri Ibrahim Cecen University. His work in these academic environments has allowed him to further his research and contribute to the scientific community.

Collaborations

Yusuf has collaborated with notable colleagues, including Serdar Durdagi and Mine Yurtsever. These partnerships have enriched his research endeavors and fostered a collaborative spirit in the pursuit of innovative solutions.

Conclusion

Yusuf Serhat Is exemplifies the spirit of innovation in the medical field, particularly in the treatment of neurodegenerative diseases. His contributions through patents and collaborations highlight the importance of research in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…